https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-07-25 15:17:592016-11-25 15:18:252013 GI Conference: AT13387, A Novel Non-Ansamycin Inhibitor of HSP 90 is Active against GIST
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-04-25 14:33:352016-11-25 14:34:012013 AACR: AT-IAP, a dual cIAP1 and XIAP antagonist with oral antitumor activity in melanoma models
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-25 16:36:202016-11-25 16:38:002012 ASH: Results from Dose Escalation Phase of Randomized Phase 1-2 FIH Study of SGI-110
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-25 15:21:032016-11-25 15:21:392012 EORTC: Activity of the HSP90 inhibitor AT13387 in ALK-driven tumor models
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-25 14:34:122016-11-25 14:34:402012 Apoptosis and Cancer: A Potent XIAP And cIAP1 Dual Antagonist Is Effective In Melanoma Models
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-23 16:38:392016-11-25 16:38:582012 AACR: Chemosensitizing effects of DNA methylation inhibitor SGI-110 in Ovarian Cancer
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-20 16:39:062016-11-25 16:39:262012 AACR: SGI-110, a novel SQ second generation DNA hypomethylating agent
